Kiniksa Pharmaceuticals International PLC (KNSA)
21.11
-0.06
(-0.30%)
USD |
NASDAQ |
Dec 04, 16:00
21.11
0.00 (0.00%)
After-Hours: 20:00
Kiniksa Pharmaceuticals International Profit Margin (Quarterly): -11.31% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -11.31% |
| June 30, 2024 | -3.60% |
| March 31, 2024 | -22.17% |
| December 31, 2023 | 30.26% |
| September 30, 2023 | -20.66% |
| June 30, 2023 | 20.95% |
| March 31, 2023 | -25.38% |
| Date | Value |
|---|---|
| December 31, 2022 | 7.21% |
| September 30, 2022 | |
| June 30, 2022 | -74.08% |
| March 31, 2022 | -78.32% |
| December 31, 2021 | -193.8% |
| September 30, 2021 | -252.5% |
| June 30, 2021 | -539.5% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-539.5%
Minimum
Jun 2021
30.26%
Maximum
Dec 2023
-89.46%
Average
-22.17%
Median
Mar 2024
Profit Margin (Quarterly) Benchmarks
| Pfizer Inc | 25.22% |
| NovaBay Pharmaceuticals Inc | -49.65% |
| Palatin Technologies Inc | -- |
| iBio Inc | -- |
| Theriva Biologics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -2.11% |
| Return on Assets | -1.73% |
| Return on Invested Capital | -2.11% |
| Gross Profit Margin (Quarterly) | 55.96% |
| Operating Margin (Quarterly) | -8.61% |
| Return on Net Operating Assets | -11.88% |